Analysis of Merck share price

--- Advertisement ---
76.4% of retail investor accounts lose money when trading CFDs with this provider.
Chart provided by Tradingview

Elements that can influence the price of this asset:

Analysis N°1

First of all, all the innovations of the medical and pharmaceutical sector worldwide should be monitored and not only for the Merck group.

Analysis N°2

You should also closely monitor the investments made by Merck in order to position itself in the underdeveloped and developing countries that have enormous health needs as well as the evolution of its situation in emerging markets.

Analysis N°3

The Merck group could also use its vast expertise and various resources to develop sustainable solutions in countries around the world.

Analysis N°4

You should also keep a close eye on the developments and innovations of the Merck group and in particular its research partnerships.

Analysis N°5

Finally, it goes without saying that the particularly tenacious competition in this sector of activity should also be watched.

--- Advertisement ---
Trade Merck shares!
76.4% of retail investor accounts lose money when trading CFDs with this provider.

General presentation of Merck:

The Merck group is one of the leading names in the pharmaceutical industry, specializing in the design, production and marketing of therapeutic products and vaccines. The activity which brings in the most turnover is the sale of pharmaceutical products. Next comes the vaccine sales, and other complementary activities.

The market most targeted by Merck is the United States, but this group also works a lot with Europe, the Middle East, Africa and Japan.


Knowing Merck shares competition:

The Merck group is one of the leaders in the pharmaceutical sector worldwide, particularly with regard to vaccines. Here are its main competitors which you should take into account when analysing its share price.


The strategic alliances set up by the Merck group:

To succeed in your Merck share price analysis, it's also essential to know the main worldwide partners of this group. Check out the major partnerships set up by Merck in the past.


Introduction and stock quote of the Merck share:

The Merck share is listed on Euronext Paris. But its price is also included in the calculation of the Dow Jones stock market index (DJIA).


Economic history


The advantages and strengths of the Merck share as a stock exchange asset :

The first great advantage of the Merck Group is its brand name, which is known worldwide. The Merck brand is one of the strongest brands in the pharmaceutical industry, which makes it easier to market its products and promote them to physicians and specialists.

In addition, the Merck group has a particularly large and, above all, highly diversified portfolio of pharmaceutical products and treatments. This enables it to reach different segments of the population and to offer solutions to a wide range of health problems and illnesses.

Merck's brand image is also positively supported by the company's charitable activities, especially in the United States, where Merck provides free medical aid to the most disadvantaged people.

Of course, Merck also invests a great deal of money in research and development every year, making it an innovative pharmaceutical company and setting it apart from the competition in this sector.

The strong international presence of the Merck Group is also appreciated, as it markets its products throughout Europe as well as in Africa, Asia, Oceania and Latin America. Through its various laboratories and research centers but also for the commercial part, Merck employs more than 40,000 people worldwide.


Disadvantages and weaknesses of the Merck share as a stock exchange asset :

Of course, the Merck group not only has advantages and arguments in its favor, but also some weaknesses that you have to compare with its strengths in order to carry out an effective fundamental analysis of the stock. Here is a list of the main weaknesses.

First of all, the Merck group regularly suffers from problems of imitation of its main drugs, which have had the effect of affecting its brand image and thus lowering the confidence of consumers who have become more distrustful. This has had a non-negligible impact on the group's sales and profitability.

Finally, the group's second major weakness this time is that it has not yet managed to position itself sufficiently effectively in emerging markets. Brand recall in these economies remains too low for Merck, which is largely overtaken by the competition. This represents a considerable shortfall compared to the opportunities in these high-demand markets.

--- Advertisement ---
Trade Merck shares!
76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.